Thomas J. Schall's most recent trade in Immuneering Corp - Ordinary Shares Class A was a trade of 8,588 Stock Option done . Disclosure was reported to the exchange on June 12, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Immuneering Corp - Ordinar... | Thomas J. Schall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 8,588 | 8,588 | - | - | Stock Option | |
Immuneering Corp - Ordinar... | Thomas J. Schall | Director | Purchase of securities on an exchange or from another person at price $ 2.55 per share. | 22 Mar 2024 | 2,900 | 2,900 | - | 2.5 | 7,385 | Class A Common Stock |
Immuneering Corp - Ordinar... | Thomas J. Schall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 35,000 | 35,000 | - | - | Stock Option |